| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pediatric Obesity | 9 | 2022 | 35 | 3.030 |
Why?
|
| Exercise | 27 | 2024 | 173 | 2.930 |
Why?
|
| Humans | 93 | 2024 | 4936 | 1.950 |
Why?
|
| Fractures, Ununited | 6 | 2016 | 6 | 1.400 |
Why?
|
| Health Promotion | 8 | 2021 | 31 | 1.280 |
Why?
|
| Adult | 49 | 2023 | 1567 | 1.250 |
Why?
|
| Female | 59 | 2023 | 2523 | 1.200 |
Why?
|
| Orthopedic Procedures | 3 | 2019 | 6 | 1.170 |
Why?
|
| Smoking Cessation | 8 | 2021 | 135 | 1.160 |
Why?
|
| Feeding Behavior | 8 | 2021 | 47 | 1.110 |
Why?
|
| Parents | 5 | 2023 | 58 | 1.060 |
Why?
|
| Male | 49 | 2024 | 2491 | 1.030 |
Why?
|
| Obesity | 10 | 2021 | 115 | 0.970 |
Why?
|
| Body Mass Index | 16 | 2021 | 98 | 0.960 |
Why?
|
| Tibial Fractures | 2 | 2016 | 2 | 0.910 |
Why?
|
| Quality of Life | 6 | 2022 | 87 | 0.850 |
Why?
|
| Body Weight | 7 | 2020 | 58 | 0.810 |
Why?
|
| Diet | 8 | 2021 | 40 | 0.810 |
Why?
|
| Prosthesis-Related Infections | 2 | 2019 | 2 | 0.740 |
Why?
|
| Shoulder Joint | 6 | 2017 | 10 | 0.730 |
Why?
|
| Child | 13 | 2022 | 627 | 0.710 |
Why?
|
| Middle Aged | 27 | 2021 | 967 | 0.690 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2021 | 4 | 0.690 |
Why?
|
| Substance-Related Disorders | 4 | 2021 | 47 | 0.660 |
Why?
|
| Workplace | 7 | 2021 | 38 | 0.650 |
Why?
|
| Program Evaluation | 4 | 2020 | 23 | 0.650 |
Why?
|
| Fracture Fixation, Internal | 3 | 2018 | 3 | 0.640 |
Why?
|
| Disabled Persons | 4 | 2021 | 11 | 0.640 |
Why?
|
| T-Lymphocytes | 6 | 2020 | 46 | 0.630 |
Why?
|
| Orthopedics | 1 | 2019 | 8 | 0.630 |
Why?
|
| Energy Intake | 3 | 2018 | 10 | 0.620 |
Why?
|
| Housing | 2 | 2020 | 9 | 0.620 |
Why?
|
| Public Health | 2 | 2021 | 19 | 0.620 |
Why?
|
| Preventive Health Services | 2 | 2020 | 7 | 0.620 |
Why?
|
| Femoral Fractures | 2 | 2016 | 2 | 0.610 |
Why?
|
| Knee Joint | 3 | 2018 | 6 | 0.590 |
Why?
|
| Surveys and Questionnaires | 11 | 2021 | 258 | 0.590 |
Why?
|
| Research Design | 7 | 2020 | 29 | 0.570 |
Why?
|
| Social Environment | 2 | 2015 | 12 | 0.570 |
Why?
|
| Fracture Healing | 3 | 2016 | 4 | 0.560 |
Why?
|
| Young Adult | 21 | 2021 | 787 | 0.550 |
Why?
|
| Videotape Recording | 1 | 2017 | 3 | 0.540 |
Why?
|
| Overweight | 8 | 2021 | 40 | 0.530 |
Why?
|
| Knee | 1 | 2017 | 1 | 0.530 |
Why?
|
| Child, Preschool | 9 | 2023 | 180 | 0.530 |
Why?
|
| Lower Extremity | 1 | 2016 | 5 | 0.510 |
Why?
|
| Exercise Test | 4 | 2015 | 41 | 0.510 |
Why?
|
| Schools | 4 | 2021 | 37 | 0.490 |
Why?
|
| Stem Cells | 1 | 2016 | 33 | 0.490 |
Why?
|
| Arthroplasty, Replacement | 4 | 2017 | 6 | 0.470 |
Why?
|
| Food Preferences | 1 | 2015 | 3 | 0.460 |
Why?
|
| Health Policy | 1 | 2015 | 7 | 0.460 |
Why?
|
| Aged | 16 | 2021 | 703 | 0.450 |
Why?
|
| Adolescent | 14 | 2022 | 758 | 0.450 |
Why?
|
| Primary Health Care | 1 | 2015 | 46 | 0.430 |
Why?
|
| Comparative Effectiveness Research | 1 | 2013 | 2 | 0.420 |
Why?
|
| Quality Indicators, Health Care | 1 | 2013 | 2 | 0.420 |
Why?
|
| Absorptiometry, Photon | 3 | 2018 | 8 | 0.420 |
Why?
|
| Pain | 1 | 2013 | 41 | 0.400 |
Why?
|
| Tobacco Use | 6 | 2021 | 19 | 0.390 |
Why?
|
| Oxygen Consumption | 2 | 2014 | 23 | 0.390 |
Why?
|
| Tobacco Products | 3 | 2021 | 36 | 0.390 |
Why?
|
| Waist Circumference | 2 | 2014 | 8 | 0.390 |
Why?
|
| Physical Fitness | 4 | 2014 | 22 | 0.380 |
Why?
|
| Statistics as Topic | 1 | 2011 | 8 | 0.370 |
Why?
|
| Smoking | 4 | 2021 | 89 | 0.360 |
Why?
|
| Abdominal Fat | 1 | 2011 | 3 | 0.360 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 6 | 0.360 |
Why?
|
| Residence Characteristics | 4 | 2016 | 23 | 0.360 |
Why?
|
| Treatment Outcome | 9 | 2021 | 177 | 0.350 |
Why?
|
| Tobacco Use Disorder | 3 | 2020 | 49 | 0.350 |
Why?
|
| Cytomegalovirus Infections | 4 | 2015 | 25 | 0.350 |
Why?
|
| Body Height | 1 | 2010 | 4 | 0.340 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 2 | 2021 | 5 | 0.340 |
Why?
|
| Texas | 9 | 2021 | 190 | 0.330 |
Why?
|
| Weight Reduction Programs | 2 | 2021 | 7 | 0.320 |
Why?
|
| Parenting | 3 | 2021 | 48 | 0.310 |
Why?
|
| Bulimia | 3 | 2015 | 6 | 0.310 |
Why?
|
| Spinal Cord Injuries | 2 | 2019 | 18 | 0.300 |
Why?
|
| Behavior Therapy | 4 | 2021 | 28 | 0.290 |
Why?
|
| Life Style | 2 | 2021 | 11 | 0.290 |
Why?
|
| Pancreatic Neoplasms | 2 | 2019 | 15 | 0.290 |
Why?
|
| Pregnant Women | 2 | 2020 | 7 | 0.290 |
Why?
|
| United States | 7 | 2022 | 495 | 0.280 |
Why?
|
| Heart Rate | 5 | 2020 | 43 | 0.280 |
Why?
|
| Shoulder Prosthesis | 2 | 2017 | 4 | 0.280 |
Why?
|
| Arthroplasty, Replacement, Shoulder | 2 | 2017 | 4 | 0.280 |
Why?
|
| Parent-Child Relations | 3 | 2021 | 43 | 0.270 |
Why?
|
| Women | 2 | 2020 | 4 | 0.270 |
Why?
|
| Up-Regulation | 2 | 2024 | 28 | 0.260 |
Why?
|
| Pilot Projects | 4 | 2021 | 98 | 0.250 |
Why?
|
| Fracture Fixation, Intramedullary | 2 | 2016 | 2 | 0.250 |
Why?
|
| Models, Biological | 2 | 2018 | 124 | 0.250 |
Why?
|
| Bone Plates | 2 | 2016 | 5 | 0.240 |
Why?
|
| Receptors, Adrenergic, beta-2 | 2 | 2024 | 11 | 0.240 |
Why?
|
| Adiposity | 3 | 2015 | 20 | 0.240 |
Why?
|
| Body Composition | 6 | 2018 | 17 | 0.230 |
Why?
|
| Killer Cells, Natural | 2 | 2015 | 32 | 0.230 |
Why?
|
| Motor Activity | 6 | 2018 | 61 | 0.220 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 43 | 0.220 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2024 | 2 | 0.220 |
Why?
|
| Cross-Sectional Studies | 8 | 2021 | 269 | 0.210 |
Why?
|
| Bisoprolol | 2 | 2021 | 9 | 0.210 |
Why?
|
| Nadolol | 2 | 2021 | 10 | 0.210 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2021 | 10 | 0.210 |
Why?
|
| Postural Balance | 2 | 2015 | 28 | 0.210 |
Why?
|
| Leg | 2 | 2021 | 11 | 0.200 |
Why?
|
| Health Surveys | 2 | 2015 | 13 | 0.200 |
Why?
|
| Muscle, Skeletal | 3 | 2018 | 78 | 0.200 |
Why?
|
| Pregnancy Complications | 2 | 2020 | 10 | 0.200 |
Why?
|
| Mobile Applications | 1 | 2023 | 14 | 0.200 |
Why?
|
| Evidence-Based Practice | 3 | 2020 | 11 | 0.190 |
Why?
|
| Socioeconomic Factors | 4 | 2015 | 38 | 0.190 |
Why?
|
| Health Status | 3 | 2023 | 27 | 0.190 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2020 | 14 | 0.190 |
Why?
|
| Walking | 3 | 2019 | 39 | 0.190 |
Why?
|
| Telemedicine | 1 | 2023 | 37 | 0.190 |
Why?
|
| Personal Satisfaction | 2 | 2019 | 24 | 0.190 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2020 | 21 | 0.180 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2014 | 17 | 0.180 |
Why?
|
| Cell Differentiation | 4 | 2015 | 71 | 0.180 |
Why?
|
| Prospective Studies | 6 | 2019 | 111 | 0.180 |
Why?
|
| Massachusetts | 1 | 2021 | 2 | 0.180 |
Why?
|
| Bone Lengthening | 1 | 2021 | 2 | 0.180 |
Why?
|
| Recovery of Function | 2 | 2019 | 18 | 0.180 |
Why?
|
| Algorithms | 2 | 2014 | 241 | 0.180 |
Why?
|
| Leisure Activities | 1 | 2021 | 7 | 0.170 |
Why?
|
| Glenoid Cavity | 2 | 2017 | 2 | 0.170 |
Why?
|
| Erythropoietin | 1 | 2021 | 3 | 0.170 |
Why?
|
| Physical Endurance | 1 | 2021 | 7 | 0.170 |
Why?
|
| Physician's Role | 1 | 2021 | 3 | 0.170 |
Why?
|
| Health Plan Implementation | 1 | 2021 | 6 | 0.170 |
Why?
|
| Health Services | 1 | 2021 | 8 | 0.170 |
Why?
|
| Architectural Accessibility | 1 | 2020 | 1 | 0.170 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 20 | 0.170 |
Why?
|
| Smoke-Free Policy | 1 | 2020 | 5 | 0.170 |
Why?
|
| Cellular Senescence | 2 | 2011 | 14 | 0.170 |
Why?
|
| Social Support | 3 | 2018 | 28 | 0.170 |
Why?
|
| Retrospective Studies | 6 | 2021 | 341 | 0.170 |
Why?
|
| Tobacco Use Cessation | 1 | 2020 | 6 | 0.170 |
Why?
|
| Capacity Building | 1 | 2020 | 7 | 0.170 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2020 | 3 | 0.170 |
Why?
|
| Femur | 2 | 2021 | 4 | 0.170 |
Why?
|
| Adrenergic beta-2 Receptor Antagonists | 1 | 2020 | 5 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2020 | 16 | 0.170 |
Why?
|
| Viruses | 1 | 2020 | 11 | 0.170 |
Why?
|
| Child Health Services | 1 | 2020 | 2 | 0.160 |
Why?
|
| Community Health Services | 1 | 2020 | 6 | 0.160 |
Why?
|
| Graft vs Tumor Effect | 1 | 2020 | 2 | 0.160 |
Why?
|
| Receptors, Adrenergic | 1 | 2020 | 3 | 0.160 |
Why?
|
| Health Behavior | 3 | 2015 | 34 | 0.160 |
Why?
|
| Maternal Behavior | 1 | 2020 | 11 | 0.160 |
Why?
|
| Family Characteristics | 1 | 2020 | 17 | 0.160 |
Why?
|
| Cigarette Smoking | 1 | 2020 | 39 | 0.160 |
Why?
|
| Bone Transplantation | 2 | 2016 | 2 | 0.160 |
Why?
|
| Patient Compliance | 2 | 2023 | 17 | 0.160 |
Why?
|
| Postoperative Complications | 2 | 2016 | 11 | 0.160 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 26 | 0.150 |
Why?
|
| Community Health Centers | 1 | 2019 | 4 | 0.150 |
Why?
|
| Paraplegia | 1 | 2018 | 4 | 0.150 |
Why?
|
| Preoperative Care | 1 | 2018 | 7 | 0.150 |
Why?
|
| Factor Analysis, Statistical | 2 | 2017 | 39 | 0.140 |
Why?
|
| Distance Counseling | 1 | 2018 | 2 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2015 | 37 | 0.140 |
Why?
|
| Adenoviridae | 1 | 2018 | 2 | 0.140 |
Why?
|
| Adoptive Transfer | 1 | 2018 | 4 | 0.140 |
Why?
|
| Dendritic Cells | 2 | 2015 | 7 | 0.140 |
Why?
|
| Neoplasms | 1 | 2020 | 90 | 0.140 |
Why?
|
| Nutrition Policy | 1 | 2018 | 1 | 0.140 |
Why?
|
| Electromyography | 1 | 2018 | 37 | 0.140 |
Why?
|
| Osteotomy | 1 | 2018 | 1 | 0.140 |
Why?
|
| Joint Deformities, Acquired | 1 | 2018 | 1 | 0.140 |
Why?
|
| Ilizarov Technique | 1 | 2018 | 1 | 0.140 |
Why?
|
| Running | 2 | 2021 | 15 | 0.140 |
Why?
|
| Bone Cements | 1 | 2017 | 1 | 0.140 |
Why?
|
| Cell Survival | 1 | 2018 | 54 | 0.140 |
Why?
|
| Osteoarthritis, Knee | 1 | 2018 | 4 | 0.140 |
Why?
|
| Joint Prosthesis | 2 | 2014 | 2 | 0.140 |
Why?
|
| Movement | 1 | 2018 | 52 | 0.140 |
Why?
|
| Regression Analysis | 3 | 2012 | 30 | 0.140 |
Why?
|
| Osteoarthritis | 1 | 2017 | 4 | 0.140 |
Why?
|
| Binge-Eating Disorder | 2 | 2015 | 5 | 0.140 |
Why?
|
| Monocytes | 2 | 2015 | 18 | 0.130 |
Why?
|
| Community-Based Participatory Research | 1 | 2017 | 7 | 0.130 |
Why?
|
| Nutritional Status | 2 | 2021 | 6 | 0.130 |
Why?
|
| Intuition | 1 | 2017 | 3 | 0.130 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 4 | 0.130 |
Why?
|
| Eating | 1 | 2017 | 18 | 0.130 |
Why?
|
| Herpes Simplex | 2 | 2014 | 7 | 0.130 |
Why?
|
| Gait | 1 | 2017 | 26 | 0.130 |
Why?
|
| Joint Instability | 1 | 2016 | 1 | 0.130 |
Why?
|
| Reoperation | 4 | 2017 | 10 | 0.130 |
Why?
|
| Radius Fractures | 1 | 2016 | 1 | 0.130 |
Why?
|
| Ulna Fractures | 1 | 2016 | 1 | 0.130 |
Why?
|
| Weight-Bearing | 2 | 2014 | 16 | 0.130 |
Why?
|
| Bony Callus | 1 | 2016 | 1 | 0.130 |
Why?
|
| Osteogenesis | 1 | 2016 | 3 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 2016 | 6 | 0.130 |
Why?
|
| Adipose Tissue | 2 | 2018 | 18 | 0.130 |
Why?
|
| Prosthesis Design | 4 | 2017 | 20 | 0.120 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 8 | 0.120 |
Why?
|
| Aged, 80 and over | 5 | 2016 | 262 | 0.120 |
Why?
|
| Follow-Up Studies | 4 | 2017 | 83 | 0.120 |
Why?
|
| Blood Pressure | 4 | 2020 | 40 | 0.120 |
Why?
|
| Open Fracture Reduction | 1 | 2016 | 1 | 0.120 |
Why?
|
| Immunosenescence | 1 | 2015 | 3 | 0.120 |
Why?
|
| Virus Latency | 1 | 2015 | 6 | 0.120 |
Why?
|
| Leg Bones | 1 | 2015 | 1 | 0.120 |
Why?
|
| Arm Bones | 1 | 2015 | 1 | 0.120 |
Why?
|
| Data Collection | 1 | 2015 | 14 | 0.120 |
Why?
|
| Actigraphy | 1 | 2015 | 15 | 0.120 |
Why?
|
| Time Factors | 4 | 2017 | 163 | 0.120 |
Why?
|
| Phenotype | 4 | 2020 | 67 | 0.120 |
Why?
|
| Vegetables | 2 | 2012 | 7 | 0.120 |
Why?
|
| Depression | 2 | 2017 | 125 | 0.120 |
Why?
|
| Fruit | 2 | 2012 | 12 | 0.120 |
Why?
|
| Beverages | 1 | 2015 | 1 | 0.120 |
Why?
|
| Sweetening Agents | 1 | 2015 | 1 | 0.120 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 7 | 0.110 |
Why?
|
| Anthropometry | 2 | 2011 | 11 | 0.110 |
Why?
|
| Crime | 1 | 2015 | 5 | 0.110 |
Why?
|
| Lymphoma | 1 | 2015 | 5 | 0.110 |
Why?
|
| Odds Ratio | 2 | 2014 | 17 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 8 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2015 | 8 | 0.110 |
Why?
|
| Perception | 1 | 2015 | 32 | 0.110 |
Why?
|
| Tendon Injuries | 1 | 2014 | 2 | 0.110 |
Why?
|
| Rotator Cuff | 1 | 2014 | 2 | 0.110 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 10 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 17 | 0.110 |
Why?
|
| Pregnancy | 3 | 2020 | 89 | 0.110 |
Why?
|
| Resistance Training | 1 | 2014 | 5 | 0.110 |
Why?
|
| Social Control, Informal | 1 | 2014 | 3 | 0.110 |
Why?
|
| Self Efficacy | 3 | 2019 | 34 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2014 | 18 | 0.110 |
Why?
|
| Joint Diseases | 1 | 2014 | 1 | 0.110 |
Why?
|
| Child Behavior | 1 | 2014 | 17 | 0.110 |
Why?
|
| Restaurants | 1 | 2014 | 2 | 0.110 |
Why?
|
| Fast Foods | 1 | 2014 | 3 | 0.110 |
Why?
|
| Herpesvirus 1, Human | 1 | 2014 | 3 | 0.110 |
Why?
|
| Coinfection | 1 | 2014 | 3 | 0.110 |
Why?
|
| Urban Health | 1 | 2014 | 5 | 0.110 |
Why?
|
| Disability Evaluation | 1 | 2013 | 4 | 0.110 |
Why?
|
| Biomechanical Phenomena | 4 | 2017 | 154 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 5 | 0.100 |
Why?
|
| Cognition | 1 | 2015 | 140 | 0.100 |
Why?
|
| Achilles Tendon | 1 | 2013 | 4 | 0.100 |
Why?
|
| Flow Cytometry | 4 | 2015 | 39 | 0.100 |
Why?
|
| Sarcolemma | 1 | 2013 | 6 | 0.100 |
Why?
|
| Myofibrils | 1 | 2013 | 4 | 0.100 |
Why?
|
| Vibration | 1 | 2013 | 16 | 0.100 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2012 | 3 | 0.100 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2012 | 3 | 0.100 |
Why?
|
| Range of Motion, Articular | 3 | 2017 | 9 | 0.100 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 32 | 0.100 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 2020 | 19 | 0.100 |
Why?
|
| Radiography | 3 | 2017 | 6 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2024 | 6 | 0.090 |
Why?
|
| Group Processes | 1 | 2012 | 3 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2012 | 3 | 0.090 |
Why?
|
| Spirometry | 1 | 2011 | 7 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2013 | 86 | 0.090 |
Why?
|
| Women's Health | 1 | 2011 | 1 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2018 | 127 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 318 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 17 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2021 | 48 | 0.090 |
Why?
|
| Self Report | 3 | 2019 | 67 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 137 | 0.090 |
Why?
|
| Creatine Kinase | 1 | 2010 | 3 | 0.090 |
Why?
|
| Blood Specimen Collection | 1 | 2010 | 4 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 10 | 0.090 |
Why?
|
| Risk Factors | 3 | 2016 | 159 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2010 | 115 | 0.080 |
Why?
|
| Telomere | 1 | 2010 | 5 | 0.080 |
Why?
|
| Health Education | 2 | 2020 | 15 | 0.080 |
Why?
|
| Decision Trees | 2 | 2022 | 9 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 160 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2020 | 115 | 0.080 |
Why?
|
| Cell Movement | 1 | 2010 | 61 | 0.080 |
Why?
|
| Peer Group | 2 | 2019 | 25 | 0.080 |
Why?
|
| Weight Gain | 2 | 2020 | 27 | 0.070 |
Why?
|
| Transplantation, Homologous | 2 | 2020 | 7 | 0.070 |
Why?
|
| Psychometrics | 2 | 2021 | 94 | 0.070 |
Why?
|
| Lactic Acid | 2 | 2020 | 9 | 0.070 |
Why?
|
| Linear Models | 3 | 2012 | 58 | 0.070 |
Why?
|
| Mice | 2 | 2024 | 685 | 0.060 |
Why?
|
| Healthy Volunteers | 2 | 2018 | 37 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 47 | 0.060 |
Why?
|
| Polyethylene | 2 | 2017 | 3 | 0.060 |
Why?
|
| Transplantation, Autologous | 2 | 2016 | 6 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2015 | 70 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2024 | 4 | 0.050 |
Why?
|
| Leukemia | 1 | 2024 | 6 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 29 | 0.050 |
Why?
|
| Accelerometry | 1 | 2023 | 11 | 0.050 |
Why?
|
| Age Factors | 2 | 2014 | 65 | 0.050 |
Why?
|
| Animals | 2 | 2024 | 1711 | 0.050 |
Why?
|
| Smartphone | 1 | 2023 | 15 | 0.050 |
Why?
|
| Lectins, C-Type | 2 | 2014 | 6 | 0.050 |
Why?
|
| Receptors, Immunologic | 2 | 2014 | 9 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2014 | 18 | 0.050 |
Why?
|
| Leg Length Inequality | 1 | 2021 | 2 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2021 | 2 | 0.040 |
Why?
|
| Bone Nails | 1 | 2021 | 5 | 0.040 |
Why?
|
| Smoking Prevention | 1 | 2021 | 8 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 15 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 73 | 0.040 |
Why?
|
| Bicycling | 1 | 2021 | 7 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 31 | 0.040 |
Why?
|
| Infant | 1 | 2021 | 78 | 0.040 |
Why?
|
| Transportation | 1 | 2020 | 5 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 73 | 0.040 |
Why?
|
| Emigration and Immigration | 1 | 2020 | 6 | 0.040 |
Why?
|
| Program Development | 1 | 2020 | 6 | 0.040 |
Why?
|
| Focus Groups | 1 | 2020 | 13 | 0.040 |
Why?
|
| Species Specificity | 1 | 2020 | 14 | 0.040 |
Why?
|
| Catecholamines | 1 | 2020 | 8 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2020 | 8 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2020 | 18 | 0.040 |
Why?
|
| School Health Services | 1 | 2020 | 4 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 2020 | 7 | 0.040 |
Why?
|
| Cytokines | 1 | 2020 | 37 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2020 | 3 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 15 | 0.040 |
Why?
|
| Peptides | 1 | 2020 | 49 | 0.040 |
Why?
|
| Cell Line | 1 | 2020 | 84 | 0.040 |
Why?
|
| Mexican Americans | 1 | 2019 | 14 | 0.040 |
Why?
|
| Behavioral Medicine | 1 | 2019 | 2 | 0.040 |
Why?
|
| Community-Institutional Relations | 1 | 2019 | 6 | 0.040 |
Why?
|
| Health Personnel | 1 | 2019 | 20 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 10 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2019 | 24 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2018 | 11 | 0.040 |
Why?
|
| Nutrition Therapy | 1 | 2018 | 2 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2018 | 3 | 0.040 |
Why?
|
| Healthy Lifestyle | 1 | 2018 | 3 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 12 | 0.040 |
Why?
|
| Body Fluid Compartments | 1 | 2018 | 1 | 0.040 |
Why?
|
| Calorimetry, Indirect | 1 | 2018 | 2 | 0.040 |
Why?
|
| Diet Records | 1 | 2018 | 3 | 0.040 |
Why?
|
| Basal Metabolism | 1 | 2018 | 2 | 0.040 |
Why?
|
| Tibia | 1 | 2018 | 1 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 11 | 0.030 |
Why?
|
| Osseointegration | 1 | 2017 | 1 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2018 | 15 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 4 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2017 | 5 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 11 | 0.030 |
Why?
|
| Hand Strength | 1 | 2019 | 69 | 0.030 |
Why?
|
| Satiety Response | 1 | 2017 | 2 | 0.030 |
Why?
|
| Hunger | 1 | 2017 | 3 | 0.030 |
Why?
|
| Walking Speed | 1 | 2017 | 5 | 0.030 |
Why?
|
| Cues | 1 | 2017 | 34 | 0.030 |
Why?
|
| Debridement | 1 | 2016 | 1 | 0.030 |
Why?
|
| Fractures, Open | 1 | 2016 | 1 | 0.030 |
Why?
|
| Radius | 1 | 2016 | 1 | 0.030 |
Why?
|
| Ulna | 1 | 2016 | 1 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2016 | 2 | 0.030 |
Why?
|
| Recurrence | 1 | 2016 | 23 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 31 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2016 | 62 | 0.030 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2015 | 2 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 2015 | 12 | 0.030 |
Why?
|
| Emotions | 1 | 2017 | 75 | 0.030 |
Why?
|
| Bone Diseases, Infectious | 1 | 2015 | 1 | 0.030 |
Why?
|
| Decision Making | 1 | 2015 | 9 | 0.030 |
Why?
|
| Bulimia Nervosa | 1 | 2015 | 2 | 0.030 |
Why?
|
| Hyperphagia | 1 | 2015 | 4 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2015 | 43 | 0.030 |
Why?
|
| Dextrans | 1 | 2015 | 4 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2015 | 4 | 0.030 |
Why?
|
| Viral Matrix Proteins | 1 | 2015 | 4 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2015 | 8 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 16 | 0.030 |
Why?
|
| Norepinephrine | 1 | 2015 | 4 | 0.030 |
Why?
|
| WT1 Proteins | 1 | 2015 | 3 | 0.030 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2015 | 3 | 0.030 |
Why?
|
| Hormones | 1 | 2015 | 4 | 0.030 |
Why?
|
| Epinephrine | 1 | 2015 | 8 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2015 | 6 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 34 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2015 | 9 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2015 | 11 | 0.030 |
Why?
|
| Rotator Cuff Injuries | 1 | 2014 | 2 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 24 | 0.030 |
Why?
|
| Hemiarthroplasty | 1 | 2014 | 1 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2014 | 7 | 0.030 |
Why?
|
| Poverty | 1 | 2015 | 22 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2014 | 1 | 0.030 |
Why?
|
| Popliteal Artery | 1 | 2014 | 1 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2014 | 1 | 0.030 |
Why?
|
| Heel | 1 | 2014 | 2 | 0.030 |
Why?
|
| Registries | 1 | 2014 | 22 | 0.030 |
Why?
|
| Satiation | 1 | 2014 | 5 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2014 | 20 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2014 | 1 | 0.030 |
Why?
|
| Scapula | 1 | 2014 | 2 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2014 | 3 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 1 | 2014 | 3 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2014 | 5 | 0.030 |
Why?
|
| CD28 Antigens | 1 | 2014 | 5 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 13 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 13 | 0.030 |
Why?
|
| Food Supply | 1 | 2014 | 9 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 46 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 176 | 0.030 |
Why?
|
| Cholesterol | 1 | 2014 | 17 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2014 | 29 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 21 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 34 | 0.030 |
Why?
|
| Entropy | 1 | 2013 | 11 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2013 | 4 | 0.020 |
Why?
|
| Albumins | 1 | 2013 | 4 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2013 | 9 | 0.020 |
Why?
|
| Proprioception | 1 | 2013 | 15 | 0.020 |
Why?
|
| Fluorescence | 1 | 2013 | 14 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 26 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 27 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2012 | 8 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 51 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2013 | 13 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 18 | 0.020 |
Why?
|
| Physical Conditioning, Animal | 1 | 2013 | 29 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 76 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2011 | 2 | 0.020 |
Why?
|
| Minority Health | 1 | 2011 | 3 | 0.020 |
Why?
|
| Bias | 1 | 2011 | 7 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2011 | 16 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 184 | 0.020 |
Why?
|
| Mathematics | 1 | 2011 | 27 | 0.020 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2011 | 4 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2011 | 4 | 0.020 |
Why?
|
| Anaerobic Threshold | 1 | 2011 | 7 | 0.020 |
Why?
|
| Social Class | 1 | 2011 | 20 | 0.020 |
Why?
|
| Aging | 1 | 2012 | 109 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 216 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2010 | 13 | 0.020 |
Why?
|
| Elbow Joint | 1 | 2010 | 3 | 0.020 |
Why?
|
| Biomarkers | 1 | 2010 | 81 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 7 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 16 | 0.020 |
Why?
|